Canine Life Sciences Inc. — Form C-AR (Regulation Crowdfunding)
Canine Life Sciences Inc. of DENVER, CO filed a Form C-AR (Regulation Crowdfunding) with the SEC on 2022-03-21.
Offering
- Filed: 2022-03-21
- Form: C-AR
- Accession: 0001669191-22-000235
Issuer
- CIK: 0001857342
- Website: www.caninebiologics.com
- Legal status: Corporation
- Organized in: CO
- Incorporated: 2019-12-23
- Address: 2145 S CLERMONT ST, DENVER, CO, 80222
- Employees: 5
Financials (as filed)
- Total assets (most recent): $160K
- Cash (most recent): $25K
- Revenue (most recent): $49K
- Revenue (prior): $6K
- Net income (most recent): $-449K
- Net income (prior): $-354K
- Short-term debt: $66K
People (10)
| Name | Role | Location |
|---|
| Afshin Safavi | Board Chairman and CSO | Philadelphia, PA |
| Jeff Sutherland | Board Member | DENVER, CO |
| Jeff Sutherland | CEO | DENVER, CO |
| Jeff Sutherland | Founder, President & CEO | DENVER, CO |
| Jeff Sutherland | Principal Executive Officer | DENVER, CO |
| Charles Mueller | Board Member | DENVER, CO |
| Charles Mueller | Chief Financial Officer | DENVER, CO |
| Charles Mueller | Principal Accounting Officer | DENVER, CO |
| Charles Mueller | Principal Financial Officer | DENVER, CO |
| Timothy Bennett | Board Member | DENVER, CO |
Reg CF filing history (8)
More